These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25063876)

  • 1. IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells.
    Mizui M; Koga T; Lieberman LA; Beltran J; Yoshida N; Johnson MC; Tisch R; Tsokos GC
    J Immunol; 2014 Sep; 193(5):2168-77. PubMed ID: 25063876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
    Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
    Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
    Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu.
    Divekar AA; Dubey S; Gangalum PR; Singh RR
    J Immunol; 2011 Jan; 186(2):924-30. PubMed ID: 21149603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the existence of distinct heterogeneity among the peripheral CD4-CD8- T cells from MRL-lpr/lpr mice based on the expression of the J11d marker, activation requirements, and functional properties.
    Kakkanaiah VN; Nagarkatti M; Nagarkatti PS
    Cell Immunol; 1990 May; 127(2):442-57. PubMed ID: 2139366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F; Li T; Zhang K; Wan J; Qi X
    Int Immunopharmacol; 2016 Sep; 38():31-9. PubMed ID: 27235595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus.
    Dai H; He F; Tsokos GC; Kyttaris VC
    J Immunol; 2017 Aug; 199(3):903-910. PubMed ID: 28646040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetra-arsenic tetra-sulfide ameliorates lupus syndromes by inhibiting IL-17 producing double negative T cells.
    Zhao Y; Mu Z; Cai L; Liu X; Jia J; Zhang J
    Dermatol Ther; 2019 Jul; 32(4):e12849. PubMed ID: 30707471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
    Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
    J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice.
    Merino R; Fossati L; Iwamoto M; Takahashi S; Lemoine R; Ibnou-Zekri N; Pugliatti L; Merino J; Izui S
    J Autoimmun; 1995 Feb; 8(1):33-45. PubMed ID: 7734035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
    Drappa J; Brot N; Elkon KB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus.
    Gutierrez-Ramos JC; Andreu JL; Revilla Y; Viñuela E; Martinez C
    Nature; 1990 Jul; 346(6281):271-4. PubMed ID: 1973822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H
    J Immunol; 2014 Feb; 192(3):979-84. PubMed ID: 24391210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 regulates murine lupus.
    Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
    J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining.
    Ballok DA; Millward JM; Sakic B
    Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.